SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- HIV
An SI Board Since October 2004
Posts SubjectMarks Bans
155 12 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
30Tibotec Hi Jim, I guess the company is still private right? Praveendr.praveen-12/18/2005
29[MRK 0518. Integrase Inh.] Good on Merck! <i>Results of an Initial Phasekeokalani'nui-11/18/2005
28Looks interesting, all right. rkrw, and others, in the future could you put a htuck-11/17/2005
27Hot program. I think. Press Release Source: Tibotec Pharmaceuticals Ltd Tiborkrw-11/17/2005
26Canadian researchers' discovery could lead to therapeutic vaccines to treat russet-11/15/2005
25anormed's small molecule cxcr4 inhibitor, which just got started in the clinkeokalani'nui-10/25/2005
24[GSK/Ono -- CCR5 inhibitor fails for 2nd time on side effects; GSK pulls plug] tuck-10/25/2005
23Frog Peptides Block HIV In Lab Study 09/29/05 -- A new weapon in the battle agaiIcebrg-10/5/2005
22Yeah, OK, since your focus was on the science, I am genuinely sorry to have snaptuck-9/12/2005
21not a particular surprise, the epimmune vaccine "fails" in HIV-positivscaram(o)uche-9/9/2005
20SI glitch gave me a double post,...bummer. Did a google search and came up wirusset-9/9/2005
19I live in Canada, and read Canadian newswires to make money on stocks (full timerusset-9/9/2005
18russet's posts often focus on the experimental system and what it may tell uscaram(o)uche-9/8/2005
17Oh, please don't make me moderate this thread. I know you are Canada-centrituck-9/8/2005
16Prolonged HIV medications interruptions are possible! - A break for HIV-infectedrusset-9/7/2005
15Encouraging Immune Response Seen in ''Prime/Boost'' Phase I HIV scaram(o)uche-9/7/2005
14[APOBEC-3G: OyaGen] From EurekaAlert, though the Journal editors apparently didtuck-9/2/2005
13[Most potent fusion inhibitor yet -- Merck (Trimeris)] >>Published onlinetuck-9/2/2005
12>>ATP ENHANCES THE INHIBITORY EFFECT OF NCRTIS (NUCLEOTIDE-COMPETING RT INtuck-8/22/2005
11[Nucleotide-competing Reverse Transcriptase Inhibitors] >>Identification tuck-8/22/2005
10[Emerging anti-HIV drugs] >>Expert Opinion on Emerging Drugs May 2005, Votuck-6/28/2005
9[TNX-355 PII enrolled] >>HOUSTON, March 9 /PRNewswire-FirstCall/ -- Tanoxtuck-3/10/2005
8[control of HIV by vaccine-elicited HIV-specific T cell responses may be difficutuck-3/8/2005
7[Human Rev-interacting protein (hRIP) as a target] >>Published online beftuck-3/4/2005
6[Initial swing at elucidating MOA of alpha defensin-1: PKC a target?] >>Jtuck-3/2/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News